SCHEMBL26540427

SCHEMBL26540427

COc1cc(CC(=O)C(C)C)ccn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOX P28300 1/20 0.54
LOXL2 Q9Y4K0 1/20 0.54
ACACB O00763 2/20 0.43
FFAR1 O14842 1/20 0.42
CCNE1 P24864 7/20 0.40
CDK2 P24941 7/20 0.40
GSK3B P49841 6/20 0.40
WNT3A P56704 1/20 0.39
CYP3A4 P08684 1/20 0.38
SLC13A5 Q86YT5 1/20 0.38
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRB1 P18505 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38
GABRA2 P47869 1/20 0.38
GABRB2 P47870 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21740947 0.82 LOX (0.49) LOXLOXL2ACACBFFAR1CCNE1
SCHEMBL5510542 0.82 LOXL2 (0.59) LOXLOXL2ACACBFFAR1CCNE1
SCHEMBL22286716 0.82 LOXL2 (0.59) LOXLOXL2ACACBFFAR1CCNE1
SCHEMBL31280150 0.82 LOXL2 (0.59) LOXLOXL2ACACBFFAR1CCNE1
SCHEMBL30184846 0.81 LOX (0.57) LOXLOXL2ACACBFFAR1CCNE1
SCHEMBL30361238 0.81 LOXL2 (0.62) LOXLOXL2FFAR1CCNE1CDK2
SCHEMBL445783 0.81 LOXL2 (0.62) LOXLOXL2FFAR1CCNE1CDK2
SCHEMBL2017499 0.81 LOX (0.57) LOXLOXL2ACACBFFAR1CCNE1
SCHEMBL26474046 0.79 GABRP (0.41) FFAR1WNT3AGABRPGABRDGABRA1
SCHEMBL26544516 0.79 LOX (0.48) LOXLOXL2ACACBCCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023072096-A1 TETRAHYDROFURAN-CONTAINING POLYCYCLIC DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF 优领医药科技(香港)有限公司 2023-05-04 WO disclosed